These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33259091)

  • 1. Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant - a cross-sectional study.
    Fernandez-Nieto D; Ortega-Quijano D; Suarez-Valle A; Jimenez-Cauhe J; Jaen-Olasolo P; Fernandez-Guarino M
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e183-e185. PubMed ID: 33259091
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute acral cutaneous manifestations during the COVID-19 pandemic: a single-centre experience.
    García-Legaz Martínez M; Martínez-Doménech Á; Magdaleno-Tapial J; Valenzuela-Oñate C; Partarrieu-Mejías F; Lorca-Spröhnle J; Casanova-Esquembre A; Pérez-Ferriols A; Alegre-de Miquel V
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e692-e694. PubMed ID: 32589301
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.
    Cabrera-Hernández R; Solano-Solares E; Chica-Guzmán V; Fernández-Guarino M; Fernández-Nieto D; Ortega-Quijano D; de-Andrés-Martín A; Moreno C; Carretero-Barrio I; García-Abellás P; González-de-Olano D; de-la-Hoz-Caballer B
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e659-e662. PubMed ID: 32535943
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
    Ghazal S; Litvinov IV; Aljahani N; Jfri A; Netchiporouk E
    J Cutan Med Surg; 2020; 24(4):416-417. PubMed ID: 32391713
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumonia in Hospitalized Children During SARS-CoV-2 Pandemic. Is it All COVID-19? Comparison Between COVID and Non-COVID Pneumonia.
    Jimenez-García R; Nogueira J; Retuerta-Oliva A; Sainz T; Cano-Fernández J; Flores-Pérez P; Méndez-Echevarría A; Villalobos-Pinto E; Calleja-Gero L; Sanz-Santaeufemia FJ; Romero MP; Del Rosal T; Baquero-Artigao F; Grasa C; Calvo C
    Pediatr Infect Dis J; 2021 Mar; 40(3):e111-e113. PubMed ID: 33264212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings.
    Nuno-Gonzalez A; Martin-Carrillo P; Magaletsky K; Martin Rios MD; Herranz Mañas C; Artigas Almazan J; García Casasola G; Perez Castro E; Gallego Arenas A; Mayor Ibarguren A; Feito Rodríguez M; Lozano Masdemont B; Beato M; Ruiz Bravo E; Oliver P; Montero Vega MD; Herranz Pinto P
    Br J Dermatol; 2021 Jan; 184(1):184-185. PubMed ID: 32969503
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital.
    Méndez Maestro I; Peña Merino L; Udondo González Del Tánago B; Aramburu González A; Orbea Sopeña A; Sánchez De Vicente J; Ratón Nieto JA; Acebo Mariñas E; Gardeazabal García J
    Int J Dermatol; 2020 Nov; 59(11):1353-1357. PubMed ID: 32970840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of the SARS-CoV-2 pandemic on the start of prescriptions].
    Mendizabal Olaizola A; Valverde Bilbao E
    J Healthc Qual Res; 2020; 35(6):402-403. PubMed ID: 33115612
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported cutaneous manifestations in 1429 Brazilian COVID-19-infected patients.
    Miot HA; Ianhez M; Müller Ramos P
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e172-e173. PubMed ID: 33135246
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Main differences between the first and second waves of COVID-19 in Madrid, Spain.
    Soriano V; Ganado-Pinilla P; Sanchez-Santos M; Gómez-Gallego F; Barreiro P; de Mendoza C; Corral O
    Int J Infect Dis; 2021 Apr; 105():374-376. PubMed ID: 33684560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry.
    López-Otero D; López-Pais J; Antúnez-Muiños PJ; Cacho-Antonio C; González-Ferrero T; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2021 Jan; 74(1):105-108. PubMed ID: 32863176
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature.
    Matar S; Oulès B; Sohier P; Chosidow O; Beylot-Barry M; Dupin N; Aractingi S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e686-e689. PubMed ID: 32589293
    [No Abstract]   [Full Text] [Related]  

  • 16. International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.
    Weber GM; Zhang HG; L'Yi S; Bonzel CL; Hong C; Avillach P; Gutiérrez-Sacristán A; Palmer NP; Tan ALM; Wang X; Yuan W; Gehlenborg N; Alloni A; Amendola DF; Bellasi A; Bellazzi R; Beraghi M; Bucalo M; Chiovato L; Cho K; Dagliati A; Estiri H; Follett RW; García Barrio N; Hanauer DA; Henderson DW; Ho YL; Holmes JH; Hutch MR; Kavuluru R; Kirchoff K; Klann JG; Krishnamurthy AK; Le TT; Liu M; Loh NHW; Lozano-Zahonero S; Luo Y; Maidlow S; Makoudjou A; Malovini A; Martins MR; Moal B; Morris M; Mowery DL; Murphy SN; Neuraz A; Ngiam KY; Okoshi MP; Omenn GS; Patel LP; Pedrera Jiménez M; Prudente RA; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Serrano Balazote P; Tan BW; Tanni SE; Tibollo V; Visweswaran S; Wagholikar KB; Xia Z; Zöller D; ; Kohane IS; Cai T; South AM; Brat GA
    J Med Internet Res; 2021 Oct; 23(10):e31400. PubMed ID: 34533459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous autoimmune diseases during COVID-19 pandemic.
    Günther C; Aschoff R; Beissert S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e667-e670. PubMed ID: 32534461
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous manifestations in an Italian military COVID hub.
    Di Nunno D; Laghi A; Troiani G; Marseglia B; Anelli L; Farina E; Tarricone F; Mammana G; Catalano C; Bonito A; De Capua A; Caramanico G; Blasioli S; Astorino S
    G Ital Dermatol Venereol; 2020 Oct; 155(5):632-635. PubMed ID: 33295741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave.
    Landier J; Paireau J; Rebaudet S; Legendre E; Lehot L; Fontanet A; Cauchemez S; Gaudart J
    Sci Rep; 2021 Jun; 11(1):12756. PubMed ID: 34140557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.